Singapore set to take laboratory deal to Phase II
Singapore’s antitrust enforcer has said it will take an in-depth look into a potential merger between pathology companies Innovative Diagnostics and Quest Laboratories unless they address its concerns.
To read more
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.